RMD
Price
$198.50
Change
-$5.37 (-2.63%)
Updated
Jul 13 closing price
Capitalization
28.79B
23 days until earnings call
Intraday BUY SELL Signals
VNRX
Price
$1.30
Change
-$0.05 (-3.70%)
Updated
Jul 13 closing price
Capitalization
15.66M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RMD vs VNRX

RMD vs VNRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
RMD vs. VNRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMD is a StrongBuy and VNRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (RMD: $198.50 vs. VNRX: $1.30)
Brand notoriety: RMD and VNRX are both not notable
RMD represents the Pharmaceuticals: Other, while VNRX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: RMD: 135% vs. VNRX: 40%
Market capitalization -- RMD: $28.79B vs. VNRX: $15.66M
RMD [@Pharmaceuticals: Other] is valued at $28.79B. VNRX’s [@Medical/Nursing Services] market capitalization is $15.66M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.19B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $160.44B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.98B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 1 FA rating(s) are green whileVNRX’s FA Score has 0 green FA rating(s).

  • RMD’s FA Score: 1 green, 4 red.
  • VNRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RMD is a better buy in the long-term than VNRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 4 TA indicator(s) are bullish while VNRX’s TA Score has 6 bullish TA indicator(s).

  • RMD’s TA Score: 4 bullish, 6 bearish.
  • VNRX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VNRX is a better buy in the short-term than RMD.

Price Growth

RMD (@Pharmaceuticals: Other) experienced а -9.11% price change this week, while VNRX (@Medical/Nursing Services) price change was -3.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.62%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -16.57%.

Reported Earning Dates

RMD is expected to report earnings on Aug 06, 2026.

VNRX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+7.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($28.8B) has a higher market cap than VNRX($15.7M). RMD YTD gains are higher at: -17.154 vs. VNRX (-74.570). RMD has higher annual earnings (EBITDA): 2.18B vs. VNRX (-20.6M). RMD has more cash in the bank: 1.66B vs. VNRX (3.1M). VNRX has less debt than RMD: VNRX (11.7M) vs RMD (843M). RMD has higher revenues than VNRX: RMD (5.54B) vs VNRX (2.47M).
RMDVNRXRMD / VNRX
Capitalization28.8B15.7M183,439%
EBITDA2.18B-20.6M-10,583%
Gain YTD-17.154-74.57023%
P/E Ratio19.14N/A-
Revenue5.54B2.47M224,574%
Total Cash1.66B3.1M53,529%
Total Debt843M11.7M7,205%
FUNDAMENTALS RATINGS
RMD vs VNRX: Fundamental Ratings
RMD
VNRX
OUTLOOK RATING
1..100
2817
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
38100
PRICE GROWTH RATING
1..100
6192
P/E GROWTH RATING
1..100
83100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (13) in the Medical Specialties industry is in the same range as VNRX (39) in the Medical Or Nursing Services industry. This means that RMD’s stock grew similarly to VNRX’s over the last 12 months.

RMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as VNRX (100) in the Medical Or Nursing Services industry. This means that RMD’s stock grew similarly to VNRX’s over the last 12 months.

RMD's SMR Rating (38) in the Medical Specialties industry is somewhat better than the same rating for VNRX (100) in the Medical Or Nursing Services industry. This means that RMD’s stock grew somewhat faster than VNRX’s over the last 12 months.

RMD's Price Growth Rating (61) in the Medical Specialties industry is in the same range as VNRX (92) in the Medical Or Nursing Services industry. This means that RMD’s stock grew similarly to VNRX’s over the last 12 months.

RMD's P/E Growth Rating (83) in the Medical Specialties industry is in the same range as VNRX (100) in the Medical Or Nursing Services industry. This means that RMD’s stock grew similarly to VNRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RMDVNRX
RSI
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
57%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RMD
Daily Signal:
Gain/Loss:
VNRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTIM1.44N/A
N/A
Good Times Restaurants
JBSS86.56-0.61
-0.70%
John B Sanfilippo & Son
AME232.10-1.88
-0.80%
Ametek
DLB49.36-0.44
-0.88%
Dolby Laboratories IncClass A
IMUX14.64-0.13
-0.88%
Immunic Inc.

VNRX and

Correlation & Price change

A.I.dvisor tells us that VNRX and STRRP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
-3.70%
STRRP - VNRX
27%
Poorly correlated
+0.70%
LAB - VNRX
27%
Poorly correlated
-7.58%
SSII - VNRX
26%
Poorly correlated
-3.96%
IMDX - VNRX
24%
Poorly correlated
-9.65%
RMD - VNRX
23%
Poorly correlated
-2.63%
More